Trials / Conditions / Fibrillary Glomerulonephritis
Fibrillary Glomerulonephritis
5 registered clinical trials studyying Fibrillary Glomerulonephritis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Obinutuzumab in Treatment of Fibrillary Glomerulonephritis NCT06295770 | Mayo Clinic | Phase 2 |
| Completed | Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis NCT06680349 | University of Turin, Italy | Phase 4 |
| Unknown | A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients NCT05546047 | NephroNet, Inc. | Phase 4 |
| Completed | Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis NCT02197767 | Mayo Clinic | Phase 2 |
| Recruiting | National Registry of Rare Kidney Diseases NCT06065852 | UK Kidney Association | — |